Bill Wright | executive |
Oleg Movchan | executive |
Neal Pawar | executive |
Bradley Herring | executive |
Michael Infante | analyst |
Dylan Becker | analyst |
Matthew Kikkert | analyst |
Alexei Gogolev | analyst |
Natalie Howe | analyst |
Gabriela Borges | analyst |
Good morning, ladies and gentlemen. Thank you for standing by. Welcome to Enfusion's Fourth Quarter and Full Year 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.I'd now like to turn the call over to Bill Wright, Head of Investor Relations, to begin.
Good morning, and thank you, operator.